Ibogaine Legal Status by Country

Ibogaine's legal status varies significantly around the world. Here's a comprehensive guide to help you understand where ibogaine treatment is available.

Legal Status Overview

Detailed Information by Region

North America

  • United States: Schedule I controlled substance. FDA has not approved ibogaine for any medical use. However, the 2026 executive order may change research landscape.
  • Mexico: Legal and widely available. Most popular destination for treatment.
  • Canada: Available through Health Canada's Special Access Program. Some clinics operate.

South America

  • Brazil: Legal. Has established treatment infrastructure.
  • Argentina: Legal status unclear; treatment available in some areas.

Europe

  • Spain: Decriminalized for personal use. Treatment available.
  • Portugal: Decriminalized for personal use.
  • UK: Class A drug - illegal.
  • France: Illegal.

Oceania

  • Australia: Available through Special Access Scheme.
  • New Zealand: Available by prescription.

2026 Developments

Recent developments may affect ibogaine's legal status:

  • 2026 US Executive Order directing research on psychedelic compounds
  • Ongoing clinical trials in multiple countries
  • Growing acceptance of psychedelic-assisted therapy
  • Increased pressure for alternative addiction treatments

Important Legal Notice

Laws change frequently. Always verify current legal status before traveling for treatment. This information is for educational purposes only and should not be considered legal advice.